Therapeutic RIG-I activation by phosphorothioate-backboned oligodeoxynucleotide promotes pneumonia survival
Yongxing Wang(The University of Texas MD Anderson Cancer Center), Scott Evans(Harvard University Press), V. Kulkarni(Narsee Monjee Institute of Management Studies), Jezreel Pantaleón García(The University of Texas MD Anderson Cancer Center), S. Cusack(European Molecular Biology Laboratory), Mathilde Lethier(European Molecular Biology Laboratory)
Cited by 0
Related Papers
Desirability of Outcome Ranking (DOOR) and Response Adjusted for Duration of Antibiotic Risk (RADAR)
|Clinical Infectious Diseases|2015|340
Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study
|The Lancet Infectious Diseases|2021|338
Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study
|The Lancet Infectious Diseases|2020|328
The 2.2 A resolution crystal structure of influenza B neuraminidase and its complex with sialic acid.
|The EMBO Journal|1992|314